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Hyaluronic acid nanogel (HyA-AT) is a redox sensitive crosslinkable nanogel, obtained 
through the conjugation of a thiolated hydrophobic molecule to the hyaluronic acid chain. 
Engineered nanogel was studied for its biocompatibility, including immunocompatibility 
and hemocompatability. The nanogel did not compromise the metabolic activity or cellular 
membrane integrity of 3T3, microvascular endothelial cells, and RAW 264.7 cell lines, as 
determined by the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide and lactate 
dehydrogenase release assays. Also, we didn’t observe any apoptotic effect on these cell lines 
through the Annexin V-FITC test. Furthermore, the nanogel cell internalization was analyzed 
using murine bone marrow derived macrophages, and the in vivo and ex vivo biodistribution 
of the Cy5.5 labeled nanogel was monitored using a non-invasive near-infrared fluorescence 
imaging system. The HyA-AT 
nanogel exhibits fairly a long 
half-live in the blood stream, 
thus showing potential for 
drug delivery applications.
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1. Introduction
Nanotechnology is a fast growing field with particular 
interest for biomedicine research. Nanoparticles and other 
nanomaterials in general, offer numerous advantages 
due to their small size, drug loading ability and special 
pharmacodynamics. Due to their potential and peculiar 
characteristics are often employed to: i) target-specific 
delivery of drugs, or other molecules; ii) improve drug sta-
bility or solubility, in vitro or in vivo; iii) reduce side effects 
of biologically active compound. Therefore, it is not strange 
to realise that so many nano-systems are being investi-
gated; having several products reached the market, and 
many more undergoing clinical trials.[1,2]
However, nanoparticles attractive properties can also 
be the source of problems, mainly by the interaction 
with immune system. Engineered nanoparticles can spe-
cifically be designed either to target or avoid the immune 
system.[1] Interactions with immune system are consid-
ered beneficial when advantageous medical reactions 
are obtained, e.g. vaccination or the treatment of autoim-
mune disorders. However, nanoparticles and especially 
polymeric nanoparticles may escape the immune system 
recognition and perform its duty e.g., as drug delivery 
system.[1,2] Hyaluronic acid is a naturally occurring poly-
saccharide, ubiquitous in the human body, and with 
appealing biological properties.[3]
In 2010, Kohane and Langer defined biocompatibility 
as “an expression of the benignity of the relation between 
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a material and its biological environment”. Generally bio-
compatibility is achieved when materials interact with 
the body and do not induce unacceptable toxic, immuno-
genic, thrombogenic and/or carcinogenic effects.[4]
An HyA-AT crosslinked through redox sensitive bond 
was prepared in our research group in previous work, 
demonstrating potential for drug delivery applications.[5] 
Here, we assess the biocompatibility, immunocompat-
ibility and hemocompatibility of the engineered nanogel. 
Also, nanogels biosdistribution in healthy mice model 
was assessed by non-invasive near-infrared (NIR) fluo-
rescence imaging system. Nanogel was labeled with a 
NIR probe – Cy5.5 hydrazide – and its biodistribution was 
studied for the course of 48 h.
2. Experimental Section
2.1. Materials
All reagents used were of analytical grade. Sodium hyaluro-
nate (MW = 7.46 KDa) was purchased from Lifecore Biomedical 
(USA). AG 50W – X8 resin was purchased from Bio-Rad (USA). 
Dimethyl sulfoxide (DMSO), Tetrabutylammonium fluoride 
hydrate (TBA-F), 11-Amino-1-undecanethiol hydrochloride (AT), 
N-hydroxysulfosuccinimide (NHS), 1-ethyl-3-[3-dimethylamino-
propyl]carbodiimide hydrochloride (EDC), 3-(4,5-dimethylthiazol- 
2-yl)-2,5-diphenyl tetrazolium bromide (MTT), hydrogen nicoti-
namide adenine dinucleotide (NADH), pyruvate, haemoglobin 
from bovine blood and Drabkin’s reagent were acquired from 
Sigma-Aldrich (Italy). Fluorescein-5-thiosemicarbazide and Cy5.5 
hydrazide were purchased from Life Technologies Ltd (UK). Cell 
Culture reagents and culture medium were purchased from Bio-
chrom (Germany). The water used was distilled and ultrapurified 
(Milli-Q system).
2.2. Nanogel Assembling
HyA-AT nanogel was produced as described previously,[5] by 
chemical conjugation. Briefly, a thiolated hydrophobic molecule 
(AT) was grafted in the hyaluronic acid backbone (DS = 11%) by 
carbodiimide chemistry. The resulting amphiphilic hyaluronic 
acid conjugate was dispersed in water and stirred for a few min-
utes at room temperature. Dispersion was further filtrated by 
cellulose acetate serynge filter (pore size 0.22 μm). Engineered 
nanogel was characterized thoroughly[5] and the nanogel col-
loidal dispersion in water displayed an average size distribution 
of 80.2 +/- 0.4 nm. The nanogel dispersions used for in vitro and 
in vivo studies were filtered through cellulose acetate syringe 
filter (pore size 0.22 μm) in aseptic conditions.
HyA-AT nanogel morphology (1.0 mg mL-1) was analyzed by 
Cryo-Field-Emission Scanning Electron Microscopy (Cryo-FESEM) 
in an electron microscope (SEM/EDS: FESEM JEOL JSM6301F/
Oxford Inca Energy 350). Sample was frozen in liquid nitrogen 
and then fractured and sublimated for 10 min at -95 °C to expose 
the nanogel particles. Finally, samples were sputter-coated with 
gold and palladium at -140 °C using an accelerating voltage of 
10 kV. The observation was performed at -140 °C and 15 kV.
With the intent to evaluate the interaction of the nanogel with 
protein components of the culture medium, its size distribution 
profile by intensity was evaluated through dynamic light 
scattering (DLS). Briefly, HyA-AT nanogel was dispersed in water 
at 1.0 mg mL-1 and incubated at room temperature with FBS 
1%(v/v). Dispersions were evaluated as to their size distribution 
profile at: 0, 24, 48, and 72 h. Also, control samples of nanogel 
1 mg mL-1 and FBS 1% were also analyzed, following the same 
protocol.
2.3. Synthesis Of Hya-AT-Fluorescein Labeled Nanogel
For in vitro murine bone marrow derived macrophages (BMDM) 
cellular uptake evaluation, HyA-AT nanogel and native HyA were 
labeled with Fluorescein-5-thiosemicarbazide. Briefly, thiosemi-
carbazide group reacted with carboxylic group of hyaluronic acid 
nanogel in the presence of EDC as a coupling agent.[6–10] The 
molar ratio of Fluorescein-5-thiosemicarbazide to free carbox-
ylic acid groups of HyA-AT nanogel was 0.25. The coupling agent 
(EDC) was added to the reaction mix at an equimolar ratio to the 
free carboxylic acid groups of HyA-AT nanogel and native HyA. 
The reaction was allowed to occur overnight at room tempera-
ture, in the dark. The reaction mixture was thoroughly dialysed 
(MW cut-off 1000 Da) against distilled water to remove non-
desired reaction products. Nanogel and polymer labelling was 
confirmed by UV/vis spectroscopy at 492 nm.
2.4. Synthesis Of Hya-At-Cy5.5 Labeled Nanogel
For in vivo biodistribution study using near infrared fluorescence 
(NIRF) technology, HyA-AT nanogel and native HyA were labeled 
with Cy 5.5 – hydrazide. Hydrazide reactive moiety was conju-
gated with carboxylic groups of HyA-AT nanogel[8–11] in presence 
of EDC, as coupling agent. The molar ratio of Cy 5.5 – hydrazide 
to free carboxylic acid groups of HyA-AT nanogel and native HyA 
was 0.25. EDC was added in an equimolar ratio to the free carbox-
ylic acid groups. The reaction was allowed to occur overnight at 
room temperature, in the dark. The reaction mixture was thor-
oughly dialysed (MW cut-off 2 000 Da) against distilled water to 
remove non-desired reaction products. Nanogel and polysaccha-
ride labelling was confirmed by UV/vis spectroscopy at 649 nm.
2.5. Cell lines, Cell Culture, and Maintenance
Mus musculus, mouse embryonic fibroblasts (NIH/3T3) cell 
line was maintained in Dulbecco’s modified Eagle’s media 
(DMEM) supplemented with 10% (v/v) newborn calf serum, 
100 IU mL-1 penicillin and 0.1 mg mL-1 streptomycin. Mouse leu-
kemic monocyte macrophage (RAW 264.7) cell line was grown in 
DMEM supplemented with 10% (v/v) of heat-inactivated (FBS), 
100 IU mL-1 penicillin and 0.1 mg mL-1 streptomycin. Human 
microvascular endothelial cells (HMEC) were grown in RPMI-
1640 supplemented with 10% FBS, Epidermal Growth Factor 
(10 ng mL-1), Hydrocortisone (1 μg mL-1), 100 IU mL-1 penicillin, 
and 0.1 mg mL-1 streptomycin. All cells were maintained at a 
37 °C and 95% humidified air with 5% CO2, environment. RAW 
264.7 cells were a courtesy of Dr Hugo Rocha (Federal University 
of Rio Grande do Norte, Brazil). NIH/3T3 cells and HMEC were 
already available in the laboratory.
Macromol. Biosci. 2016,  ,  1610−1620
S. S. Pedrosa et al.
	
www.MaterialsViews.com1612 © 2016  WILEY-VCH Verlag GmbH &  Co.  KGaA, Weinheim
Macromolecular
Bioscience
www.mbs-journal.de
During subculture, cells were detached by trypsinization with 
0.05% (w/v) trypsin-EDTA after reaching 80% confluency. RAW 
264.7 cells were dislodge with a cell scraper.
Murine Bone Marrow-Derived Macrophages were collected 
from femoral and tibial mouse bone marrow of female Balb/c 
mice. Mouse femurs and tibias were collected under aseptic 
conditions and flushed with RPMI -1640. The resulting cell 
suspension was centrifuged at 500 g for 10 min. Pellet was 
resuspended in RPMI-1640 supplemented with 10 × 10-3 m HEPES, 
10% heat-inactivated FBS, 60 μg mL-1 penicillin/streptavidin, 
0.005 × 10-3 m β-mercaptoethanol (Complete RPMI) and 10% 
L929 cell conditioned medium (LCCM). To remove adherent bone 
marrow cells, cell suspension was incubated on cell culture 
dishes, overnight at 37 °C at 95% humidified air containing 5% 
CO2 atmosphere. The non-adherent cells were centrifuged at 
500 g (10 min) and seeded in 24 well plates at 5 × 105 cells per 
well, in RPMI complete medium containing 10% of LCCM, and 
incubated at 37 °C in a 5% CO2 atmosphere. 4 d after seeding 
10% of LCCM was re-added and the medium was renewed on the 
seventh day, once again with complete RPMI and 10% LCCM. After 
10 d, cells were completely differentiated into macrophages.[12,13]
2.6. In Vitro Cell Toxicity
2.6.1. Cell Proliferation Assay
Assessment of cell proliferation impairment on 3T3, HMEC, and 
RAW 264.7 cells was performed using the MTT reduction assay, 
adapted from Mosmann.[14] Cells were seeded in 24-well cell 
culture plates at a density of 1 × 104 cells per well for 3T3 and 
RAW 264.7 cells and of 2 × 104 for HMEC cells, and left adhering 
in 0.5 mL of adequate culture medium overnight. HyA-AT 
nanogel 0.1, 0.5, and 1 mg mL-1 dispersions were suspended in 
adequate culture medium, resulting in a 1:5 fresh medium dilu-
tion. For RAW 264.7 cell line the maximum concentration tested 
was 0.5 mg mL-1. Untreated cells were used as control of 100% 
cell viability. Another control with 20% distilled water was used 
to access the effect of water dilution of samples containing the 
nanogel. A positive control with 20% of DMSO was used in every 
analysis. The samples were incubated for 24, 48, and 72 h and 
the cells metabolic activity was calculated due to the reduction 
of tetrazolium salt of MTT by mitochondrial succinate dehydro-
genase enzymes of metabolically active cells. To which well, 10% 
(v/v) of a MTT solution (5 mg mL-1 in PBS) was added and it was 
incubated at 37 °C and 5% CO2 for a period of 4 h. In this period of 
time, the tetrazolium salt was bioreduced to a formazan product 
that consists of dark blue crystals that were insoluble in the cul-
ture medium. The supernatant was discarded slowly and the 
crystals were solubilized in dimethyl sulfoxide and quantified 
spectrophotometrically at 570 nm. The experiments were per-
formed in triplicates as the results were presented as percentage 
in which 100% viability corresponds to the non-treated cells.
2.6.2. Ldh Release Assay
The lactate dehydrogenase (LDH) release assay measures the 
membrane integrity as function of the amount of cytoplasmic 
LDH leaked through membrane-impaired cells. The lactate 
was converted to pyruvate in the presence of LDH with parallel 
reduction of nicotinamide adenine dinucleotide (NAD), detected 
as a change in absorbance at 340 nm.[15] Cells were seeded in 
12-well plate at a density of the 2 × 105 cells per well for 3T3 
and HMEC cell lines and 1 × 105 for RAW and allowed to settle 
overnight in 0.5 mL of adequate culture medium. The cells were 
treated with nanogel dispersions with a concentration of 0.1 
and 1.0 mg mL-1 in suitable culture medium and supplemen-
tation. The exception was RAW 264.7 cells that were incubated 
with 0.1 and 0.5 mg mL-1 nanogel dosages. Untreated cells were 
used as control of 100% cell viability. Another control with 20% 
distilled water was used to access the effect of the water dilu-
tion of the samples containing the nanogel. A control with 20% 
of DMSO was used in every analysis as a positive control. The 
samples where incubated for 24 h and after that period each 
culture medium from every well was collected and centrifuged 
at 13 000 rpm for 1 min and the cell free supernatant was col-
lected and stored on ice for further analysis – Extracellular LDH. 
Cells were scraped with a Tris solution (15 × 10-3 m) extracel-
lular and further lysed by sonication. The resulting supernatants 
were used to quantify the LDH present – Intracellular LDH. An 
aliquot of extracellular (40 μL) or intracellular (10 μL) LDH were 
assigned into a microplate and 250 μL of the NADH solution 
0.31 × 10-3 m in phosphate buffer 0.05 m, pH7.4 added to each 
well. Lastly, 10 μL of an 8.96 × 10-3 m piruvate solution in phos-
phate buffer (substrate solution) was added and immediately 
afterward the variation of the absorbance at 340 nm was read 
in a microplate spectrophotometer system, as to determine the 
rate of NADH consumption (slope of the line). LDH leakage was 
expressed as the ratio between extracellular and total LDH, corre-
sponding the inverse value to the cell membrane integrity. Each 
experiment was performed in triplicate.
2.6.3. Apoptosis Assay
The FITC Annexin V Apoptosis Detection Kit was used to detect 
apoptotic and necrotic cells in 3T3, HMEC, and RAW cell lines. 
Cells (2 × 105/well) were seeded in a 12-well plate and incubated 
overnight. Nanogel samples were added to the respective wells 
in a concentration range of 0.1 to 1.0 mg mL-1 dispersed in suit-
able culture medium and incubated for 24 h. A negative control 
without any nanogel sample but with 20% distilled water was 
used – since preliminary studies revealed that untreated cells 
and cells incubated with 1:5 distilled water, culture medium ratio 
had similar results. The positive apoptotic control was prepared 
by culturing the control cells in medium containing H2O2 with 
different incubation times and concentration accordingly to the 
cells line (0.5 × 10-3 m and 6 h incubation in RAW; 0.2 × 10-3 m 
and 24 h incubation for HMEC; and 5 × 10-3 m and 3 h incubation 
for 3T3).[16,17] Cells were then collected by trypsinization 250 μL 
trypsin/EDTA 0.25%/0.02% in PBS. Cell suspension was transferred 
to flow cytometry sample tubes (Beckman Coulter) and washed 
twice with cold PBS. Each sample was incubated with 40 μL of the 
work solution (1.8 μL of the Annexin V and PI diluted in 36.4 μL of 
the Annexin V binding buffer) for 15 min at room temperature, in 
the dark. Finally, 200 μL of Annexin V binding buffer was added 
to the samples that were then analyzed by flow cytometry using 
a Coulter Epics XL Flow Cytometer (Beckman Coulter Inc., Miami, 
FL, USA). Cells were set as positive depending on the fluorescence 
intensity of Annexin V-FITC or PI. The positive of Annexin V-FITC 
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indicates the out-releasing of phospholipid phosphatidylserine 
(PS), which happens in the early stage of apoptosis. The posi-
tive of PI indicates the damage of cell membrane, which occurs 
either in the end stage of apoptosis, in necrosis or in dead cells. 
Therefore, the apoptotic cells were identified as Annexin positive, 
and PI negatives – early apoptosis or Annexin and PI positive PI – 
late apoptosis. Nonviable cells were identified as PI positive and 
viable cells as Annexin and PI negative.[17]
2.7. Complement Activation Assay
Complement cascade was studied as reported previously[1] and 
based on the NCL (Nanotechnology Characterization Labora-
tory) protocol for qualitative determination of total complement 
activation by Western blot analysis. Briefly, a pool of human 
plasma from healthy donors was incubated with 1 mg mL-1 of 
GC nanogel in the presence of veronal buffer. Equal volumes 
(50 μL) of plasma, buffer and sample were mixed and incubated 
at 37 °C for 60 min. Cobra venom factor from Quidel Corporation 
(San Diego, CA, USA), and PBS were used as positive and negative 
controls, respectively. Proteins were resolved by 10% SDS-PAGE, 
and then transferred to a membrane (Immun-Blot PVDF Mem-
brane, Biorad, Hercules, USA) using the transblot semidry BioRad 
transfer equipment (Trans blot SD, BioRad, Hercules, USA). The 
membranes were incubated for 90 min with a mouse mono-
clonal antibody against human C3 diluted 1:1000 (Abcam, Cam-
bridge, UK), washed and incubation with secondary polyclonal 
goat anti-mouse IgG antibodies conjugated with alkaline phos-
phatase diluted 1:2000 (Dako, Glostrup, Denmark). The mem-
brane was finally revealed with 5-Bromo- 4-Chloro-3-Indolyl 
Phosphate (BCIP) (Sigma). For further analysis, membranes were 
scanned with ChemiDoc XRS+ System (Bio-Rad; Hercules, CA). 
The percentage of the lower band was then quantified with 
Image Lab Software 3.0.
2.8. Murine Bone Marrow Derived Macrophages 
Nanogel Uptake
The hyaluronic acid nanogel cytocompatibility was further ana-
lyzed by the phagocytic activity of murine BMDM. Macrophages 
were seeded in 24 well plates (5 × 105 cells/well) on top of cov-
erslip discs and were left adhering overnight. Further, cells were 
incubated for 6 h with 0.2 mg mL-1 fluorescein labeled nanogel 
dispersion in culture medium. Dextrin-FITC labeled nanoparticles 
(0.2 mg mL-1) were used as a positive control for phagocytic uptake, 
as described by Gonçalves et al.[18] Fluorescein labeled native HyA 
(0.2 mg mL-1) was used to compare its phagocytic internalization 
with the HyA-AT nanogel. Full medium was removed from all the 
wells and coverslips were washed twice with PBS at room temper-
ature and fixed with 2% paraformaldehyde solution for 25 min. 
After, 4′,6-diamidino-2-phenylindole (DAPI, 120 ng mL-1) was used 
to stain the nucleus for 3 min at room temperature. Cells were 
observed in a confocal laser scanning microscope Leica SP2 AOBS 
SE (Leica Mycrosystems, Germany).
2.9. Haemolysis Index
The haemolysis assay was performed in agreement to the proce-
dure described by the American Society for Testing Materials[19] 
and used in previous works.[20] Whole blood was collected from 
three independent healthy donors using citrated blood collection 
tubes. Briefly, 0.5 mL of diluted blood at 10 mg mL-1 was added to 
3.5 mL of the nanogel solution in PBS at 0.1, 0.5, and 0.1 mg mL-1 
and incubated at 37 °C for 3 h. The tubes were gently mixed at 
30 min frames to homogenize the mixture. Ultrapure water and 
Phosphate-buffered saline (PBS) were used as positive and nega-
tive haemolytic control, respectively. The suspension was cen-
trifuged at 750 g for 15 min and 0.5 mL of the supernatant was 
collected. Then, 0.5 mL of Drabkin’s reagent was added and the 
solution was left incubating for 15 min at room temperature. 
Finally, the absorbance at 540 nm was measured by UV–vis spec-
troscopy (JASCO V560). Haemoglobin standard solutions were 
prepared from bovine blood haemoglobin to elaborate a cali-
bration curve to infer the haemoglobin content of the samples. 
Experience was made in triplicates.
2.10. In Vivo And Ex Vivo Near-Infrared Fluorescence 
(NIRF) Imaging
All experiments with live animals were performed in compli-
ance with the Portuguese General alimentary and Veterinarian 
Board (authorization number 006315/27/03/2014, from DGAV-
Portugal) and animals were kept and used strictly in accordance 
with National rules and the European Communities Council 
Directive (86/609/EEC), for the care and handling of laboratory 
animals. Athymic nude mice CD1-Foxn1nu mice (6-weeks old) 
were purchased from Charles River Laboratories International, 
Inc. HyA-AT-Cy5.5 labeled nanogel dispersion and native HyA-
Cy5.5 solution were injected intravenously into the mice via tail 
vein (n = 5) at a 5 mg kg-1 animal body weight. At established 
time points (2, 7, 24, and 48 h) mice were anesthetised with Keta-
mine 75 mg kg-1 BW and Medetomidine 1 mg kg-1 BW solution 
prior to its analysis and blood sample collection.
The time-dependent biodistribution and accumulation profiles 
of samples were observed by using a Xenogen’s IVIS Lumina Series 
and Living Image Software. To evaluate the blood clearance at 
all time points, 50 μL venous blood was collected from the retro-
orbital vein and transferred to a 96-well plate and analyzed at 
each time point. The minimum amount of blood was collected, 
respecting the animal size and time schedule (50 μL per analysis). 
To observe the organ distribution of the samples, each group 
of mice was sacrificed with a lethal dose of anaesthesia 48 h 
post samples injection. Then, major organs were excised and 
transferred to a 6-well plate and observed using the Xenogen’s 
IVIS Lumina Series and Living Image Software. NIR fluorescence 
images obtained with a 12-bit CCD camera equipped with a special 
C-mount lens and Cy5.5 bandpass emission filter (680–720 nm).
2.11. Statistical Analysis
The results were expressed as mean ± SD of 3 independent 
experiments (n = 3). Statistical analysis was performed with 
t-test or two-way ANOVA followed by Tukey’s comparison test 
using using GraphPad Prism version 6.00 for Mac OS X, GraphPad 
Software, La Jolla California USA. Significance of the results was 
indicated according to P values with one, two, three or four of the 
used symbols (*, # or +) corresponding to P = 0.01 to 0.05; P = 0.001 
to 0.01; P = 0.0001 to 0.001 and P < 0.0001, respectively).
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3. Results And Discussion
3.1. Hya-At Nanogel Characterization
The chemical conjugation of a hydrophobic chain to HyA 
was already fully characterized in our previous study.[5] The 
resulting amphiphilic molecule (HyA-AT) self assembles in 
aqueous environment onto nanosized structures. The mor-
phology and size of the nanogel was evaluated by Cryo-
FESEM and DLS analysis regarding its size distribution by 
intensity, as shown in Figure 1a. The particles were appar-
ently spherical and well dispersed without any aggrega-
tion, and the nanogel reveals a bimodal size distribution 
with a mean size diameter of 80.2 +/- 0.4 nm (n = 5).[5]
It is well known that protein adsorption to nano-
materials has high impact on the interaction of nano-
materials with cells, both in vivo and in vitro. Therefore, 
we wanted to assess if the serum supplementation used 
in culture medium affected the size distribution profile 
Macromol. Biosci. 2016,  ,  1610−1620
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of the nanogel. As can be seen in Figure 1b, we observed 
the interaction of the nanogel with FBS 1% (v/v) by DLS 
analysis, in the course of 72 h. Indeed, nanogel showed 
colloidal stability and its average size diameter, around 
80 nm, maintained constant throughout time. The serum 
proteins size distribution profile fluctuated through time, 
probably due to the formation of unstable aggregates.
Section a: Nanogels size distribution profile by inten-
sity through DLS analysis and Cryo-Field-Emission Scan-
ning Electron Microscopy (Cryo-FESEM).
Section b: Nanogel size stability by intensity through 
DLS analysis, in the presence of serum proteins (FBS), over 
time.
3.2. Cytotoxicity Studies
Cytotoxicity studies were performed in three cell lines: 
3T3, HMEC, and RAW 264.7. 3T3 fibroblasts were chosen 
as a model for stromal cells, which can be found in matrix 
and connective tissue throughout the body. Human micro-
vascular endothelial cell line (HMEC-1) was used to inves-
tigate the possible cytotoxic effects in vasculature. RAW 
264.7 are murine macrophages cell line, which are com-
monly included in nanomaterial toxicity investigations as 
an inflammatory cell type.
In the case of RAW macrophages we only tested a 
maximum 0.5 mg mL-1, since macrophages can readily 
phagocytose nanomaterials at a very high rate and lead 
to overload and cell death. Thus, we didn’t feel the need 
to test higher concentrations in this case.[21,22] In addi-
tion to different nanogel concentrations, DMSO was 
used as a positive control and two negative controls were 
performed – one consisting of 100% culture medium and 
the other of culture medium diluted with 20% water. 
This last control is actually the most relevant one, since 
it mimics the water dilution effect with the nanogel sam-
ples (which slightly affects the cell growth).
3.2.1. Cell Proliferation
MTT is a colorimetric, easy, fast and safe assay that 
measures the mitochondrial metabolic activity of viable 
cells (Figure 2). We observed that the water-diluted con-
trol had a slightly lower cell growth or activity may be 
due to the dilution of nutrients of the culture medium. 
This effect was most noticed in the longer incubation 
time (Figure 2). The metabolic activity was not, overall, 
evidently affected be the nanogels presence, however at 
longer incubation time (72 h) and highest dose, a reduced 
cell proliferation or activity was observed in 3T3 and 
RAW cells – in comparison to the diluted medium con-
trol. RAW cells seem to be more susceptible to nanogel 
treatment, but even in this case a slightly lower prolif-
eration is observed only with highest incubation time. 
Similar results were obtained by other researchers[20,23] 
when studying nanoparticles effect on macrophage 
cell lines. For instance, poly(ethylene glycol) (PEG)-con-
jugated hyaluronic acid nanoparticles, showed dose-
dependent cytotoxicity to cancer cells (MDA-MB-231, 
SCC7, and HCT 116) and significantly lower cytotoxicity 
against normal fibroblasts (NIH-3T3).[24] Fairly high 
nanogel concentrations were tested (up to 1.0 mg mL-1) 
Macromol. Biosci. 2016,  ,  1610−1620
Figure 2. Cell viability of 3T3, HMEC, and RAW cells determined by 
MTT assay as to exposure to HyA-AT nanogel at 0.1 to 1 mg mL-1 
concentration. Non-treated cells referred to as culture medium 
are considered 100% cell viability at 72 h. Statistical analysis was 
performed using a two-way ANOVA and a Tukey’s comparison 
test. Differences between samples and culture medium at any 
given time point are represented by (*); whereas differences 
between samples and 20% dH2O diluted control at any given 
time point are represented by (#); differences between nanogel 
concentration are represented by (+).
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to effectively detect toxic effects and objectively assess 
the safety of the material.
3.2.2. Evaluation Of Membrane Cell Integrity
The evaluation of cell membrane integrity was performed 
by LDH release assay. As shown in Figure 3, membrane 
integrity was preserved at all nanogel concentrations for 
all cell lines. This indicates that the nanogel did not affect 
membrane stability in any of the cells tested – 3T3, HMEC, 
and RAW. According to Fotakis and Timbrell,[15] LDH release 
is not as sensitive as the MTT assay and requires higher 
concentration of sample or longer incubation time for 
the detection of cytotoxic effects. However, even at high 
nanogel dosage such as 1 mg mL-1, any effect was observed.
3.2.3. Apoptosis Assay
Nanogel induced apoptosis was determined by annexin 
V-FITC and PI double staining resorting to flow cytometry, 
as shown in Figure 4. Early apoptosis is characterized by 
plasma membrane reorganization (translocation of phos-
phatidylserine to the external surface), detected by posi-
tive staining for Annexin V-FITC. In later stage of apoptosis 
cells present membrane damage, therefore PI can bind to 
DNA in cytoplasm resulting in positive staining for both 
Annexin V and PI.[25] In all cell lines tested no significant 
effect by nanogels presence was noticed in comparison 
with the negative control (20% water diluted culture 
medium). Nanogel interaction with HMEC cells caused a 
slight increase in only late apoptic population (Annexin V 
positive) regarding control cells. The observed effect was 
indeed dose dependent.
3.3. Complement Activation
The nanogel effect on the complement cascade activation 
was evaluated by the cleavage of C3, which is a marker for 
both activation pathways. Western blot analysis for the 
presence of the C3 fragment was performed after incuba-
tion of the HyA-AT nanogel (at 1 mg mL-1 concentration) 
with human plasma. The results are shown in Figure 5. The 
upper band of 115 kDa corresponds to the intact C3 factor 
and the one with 43 kDa to the main degradation product. 
The protein degradation was quantified considering the 
intensity of the band at 43 kDa normalized to the value 
obtained with the positive control (cobra venom factor). 
As could be observed in Figure 5, the percentage of C3 
cleavage product(s) was similar to those found in the nega-
tive control, so it may be concluded that the nanogel does 
not activate the complement system.
3.4. Murine Bone Marrow Derived Macrophages 
Nanogel Uptake
The phagocytic recognition and nanogel uptake by BMDM 
was investigated by confocal microscopy. Murine BMDM 
are extensively used as a phagocytic model due to its 
peculiar capacity of internalizing extracellular mate-
rials by a wide range of mechanisms and entry routes.[26] 
Macrophages were incubated with Dextrin-FITC labeled 
nanogel (Figure 6a), native HyA-Fluorescein labeled 
(Figure 6b), and HyA-AT-Fluorescein labeled nanogel 
(Figure 6c), the different formulations (used at the same 
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Figure 3. Cell membrane integrity of 3T3, HMEC, and RAW cells 
determined by LDH release assay as to exposure to HyA-AT nanogel 
at 0.1 to 1 mg mL-1 concentration. Results are present as LDH release 
percentage after 24 h sample incubation. Statistical analysis was 
performed using a t-test. Differences between samples and cul-
ture medium are represented by (*); whereas differences among 
samples and 20% dH2O control are represented by (#).
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concentration) presenting similar levels 
of fluorescence. Also, untreated cells 
were observed, as a control (figure 6d). 
Gonçalves, et al.[18] have demonstrated 
that dextrin nanogels were exten-
sively recognised and internalized by 
BMDM. Therefore, dextrin-FITC labeled 
nanogel was used as a positive con-
trol (Figure 6A). As it was expected, the 
dextrin nanogel incubated BMDM cells 
presented an intense green staining, 
demonstrating much higher internaliza-
tion than the HyA-AT nanogels. Interest-
ingly, the native HyA was slightly more 
internalized by BMDM than HyA-AT 
nanogel (Figure 6). This result suggests 
a promising behaviour in vivo, i.e., the 
ability of the nanogel to escape blood 
clearance and exhibit a large circulation 
time in the vascular system.
3.5. Hemocompatibility Study
Experiment was performed in agree-
ment with the Standard Practice for 
Assessment of Haemolytic Properties of 
Materials from the American Society for 
Testing Materials (ASTM F756-00, 2000). 
Nanogel proved to be non-haemolytic at 
the concentrations tested, since the cor-
rected haemolytic index is inferior to 5% 
(Figure 7). Still, as compared to the nega-
tive control, no visible haemolytic effect 
was observed in the presence of the 
nanogel.
3.6. In Vivo Nanogel Biodistribution 
Profile
In vivo biodistribution analysis is an 
important tool to assess the potential 
of nanocarriers as delivery systems.[27] 
Figure 4. Flow cytometry analysis of 3T3, HMEC, and RAW cell line for the presence 
or absence of the Annexin v-FITC and/or PI markers. Cells were previously incubated 
with two different nanogel concentrations for 24 h. A negative control with 1:5 distilled 
water-diluted culture medium and hydrogen peroxide was used as apoptosis positive 
control. Statistical analysis was performed using a t-test and a Tukey’s comparison test. 
Differences between samples and culture 
medium are represented by (*). Dot Plots of 
the correspondent cell lines are presented at 
the right side of the image. Top left quadrants 
matches annexin V negative and PI positive 
cells (legend: PI); top right quadrants corre-
sponds to late apoptotic cells that express 
annexin V and PI positive (legend: Annexin 
+ PI); bottom right quadrants pairs with 
apoptotic cells that express annexin V posi-
tive and PI negative (legend: annexin); and 
for last, bottom left quadrants, viable cells 
that does not express neither annexin V or PI.
Macromol. Biosci. 2016,  ,  1610−1620
S. S. Pedrosa et al.
	
www.MaterialsViews.com1618 © 2016  WILEY-VCH Verlag GmbH &  Co.  KGaA, Weinheim
Macromolecular
Bioscience
www.mbs-journal.de
Nude mice were intravenously injected in the tail vein 
(5 mg kg-1 animal weight). Native HyA-Cy 5.5 was used as 
a control and administered following the same protocol.
In vivo biodistribution was monitored non-invasively 
as a function of time, over a period of 48 h (Figure 8a). At 
each time point, NIRF images of the whole animal were 
obtained and blood samples were also 
collected, from every animal, by retro-
orbital punction. By the analysis of the 
whole body images we can say that the 
animals treated with the nanogel seem 
to exhibit higher fluorescence inten-
sity at all time points, in comparison 
to native HyA treated animals, as fur-
ther confirmed by observing the blood-
collected samples. In fact, 24 h post 
injection, the native HyA fluorescence 
was almost absent from mice whole 
body (Figure 8a) and undetectable in 
the blood (Figure 8c), proving its fast 
clearance.
It is interesting to note that some 
fluorescence signal is detectable in 
nanogel treated animals even after 
24 h, indicating a fairly long half-live in 
the circulatory system, relevant for the 
development of drug delivery systems.
Each organ of the mice was withdrawn at 48 h post-
injection, and ex vivo fluorescence images were obtained 
(Figure 8). For both HyA polymer and HyA-AT nanogel 
strong signals were observed in the lung mostly, but also 
in the skin and kidney. Weak intensities were observed 
Macromol. Biosci. 2016,  ,  1610−1620
Figure 5. Analysis of HyA-AT nanogel complement activation through C3 protein cleavage 
by western blot. A) Western blot membrane is presented on the left and B) graphical 
representation of the % of C3 protein as comparison to PBS and Cobra venon, negative 
and positive controls, respectively.
Figure 6. Fluorescence images of murine BMDM obtained by confocal microscopy, incubated for 6 h 0.2 mg mL-1 suspension of: a) dextrin 
nanogel; b) native HyA; c) hyaluronic acid nanogel (HyA-AT); and d) untreated cells, as a control. Cell’s nucleus was stained blue with DAPI, 
120 ng mL-1. The green fluorescence is due to the fluorescein labeled samples.
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in heart, spleen and liver, while in the brain no fluores-
cence signal was detected. This result is consistent with 
the BMDM internalization studies, which suggest fairly 
poor recognition of the nanogel, and thus ability to 
evade the mononuclear phagocytic system. Concerning 
the observed nanogels accumulation in the lungs, other 
researchers[28–31] have also reported lung accumulation of 
nanoparticles, when labeled with Cy5.5 probe. We were 
able to further clarify the influence of NIR probe – namely 
Cy5.5 and Alexa Fluor 680 – on the nanogels pharmacoki-
netics (to be shown elsewhere) and assign the accumu-
lation in the lungs to the probe and not to the nanogel 
itself.
4. Conclusion
Amphiphilic HyA-AT conjugate was successfully syn-
thetized and self-assembled onto nanostructures with 
desirable features for drug delivery applications. The engi-
neered nanogel was extensively characterized as for its 
biocompatibility. Mitochondrial metabolic activity meas-
urements revealed that only for RAW cells challenged 
with the highest nanogel concentration at the highest 
incubation time (72 h), a slight reduction on growth rate 
was observed. However, this effect was not corroborated 
by membrane integrity evaluation or apoptosis induc-
tion. As a matter a fact, in all the cell lines tested and at all 
the time points it is not perceptible any inhibitory effect. 
Also, HyA-AT nanogel did not induce the activation of the 
Figure 8. In vivo and ex vivo biodistribution profile of HyA-AT 
nanogel and native HyA. a) Whole body NIRF images of CD1-
Foxn1nu mice treated with native HyA labeled with Cy5.5 
hydrazide and HyA-AT nanogel also labeled with the same fluoro-
phore. Top row of animals were administered with native HyA and 
bottom row with HyA-AT nanogel. b) Ex vivo NIRF images of the 
organs – Liver, Skin, Kidneys, Lungs, Spleen, Heart and Brain -, 48 h 
post sample injection. a) Blood sample collected by retro-orbital 
punction at established time point post sample administration, 
analyzed in NIRF equipment.
Figure 7. Blood hemolysis index of whole human blood from 
healthy donors after incubation with 0.1 until 1 mg mL-1 HyA-AT 
nanogel dispersions and 1:5 PBS diluted culture medium and 
hydrogen peroxide as negative and positive control, respectively.
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complement system, was poorly recognized and internal-
ized by BMDM and did not cause hemolysis. In vivo bio-
distribution studies demonstrated the nanogel has a fairly 
long circulation time, and can be detected in the blood 
flow up to 48 h. These findings suggest that the nanogel 
can be a promising drug delivery nanosystem.
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